Abstract. Transition from high to lower endemicity of hepatitis A virus (HAV) infection may portend increased public health burden with the shift of infection to older ages and increasing morbidity and mortality. This report describes age-specific prevalence of antibodies to HAV (anti-HAV) among children and young adults in Santiago, Chile, compared with previous prevalence data and assesses factors predictive for anti-HAV. In 1998, a serosurvey was performed in Metropolitan Santiago, designed to enroll a representative, age-stratified population on the basis of area of residence. A total of 784 individuals (age range, 1-24 years) were enrolled. Anti-HAV prevalence by year of life was as follows: ages 1 to 4, 12.5%; 5 to 9, 26.2%; 10 to 14, 43.4%; 15 to 19, 57.4%; 20 to 24, 73.9%. Adjusting for age, factors associated (inversely) with anti-HAV included residential areas of higher socioeconomic status (SES), parental education, and household characteristics of potable water, municipal sewage system, and the presence of a toilet or refrigerator in the house. In logistic regression analysis, only maternal years of education and residence in areas of higher SES remained independently associated with anti-HAV. Excluding those from higher SES areas, comparison of the agespecific anti-HAV prevalence data from previous studies of similar methodology in areas of lower SES revealed consistent decreases across all age groups; the age-standardized prevalence for this age range (1-24 years) dropped from 53.7% in 1990 to 40.6% in 1998. In light of the growing pool of susceptible individuals at older ages, with HAV continuing to circulate in the communities, evaluation of the feasibility of vaccination programs would be judicious.
INTRODUCTION
In developing countries, where endemic infection with hepatitis A virus (HAV) occurs early in life, the majority of infections are clinically undetected, and the agent is generally not a cause of significant morbidity. 1 With improving conditions, these countries enter a transition phase in which the virus is still prevalent in the population but improving hygienic conditions delay the average age of infection. [1] [2] [3] This older susceptible cohort is more likely to experience morbidity when infected than they would had they been infected as young children, paradoxically leading to a greater burden of disease and a significant public health problem. [1] [2] [3] [4] Thus, it is important to detect such shifts.
In Chile, HAV has proven endemic in the past, with a high prevalence of antibodies to HAV (anti-HAV). 5, 6 The rate of infection may be decreasing. [7] [8] [9] Comparison of surveys of anti-HAV prevalence over time indicates decreasing prevalence among children, 7, 8 but the validity of comparing prevalence from different periods can be questioned as a result of differences in methodology and study populations. 7, 8 This report describes age-specific anti-HAV prevalence among children and young adults in Santiago, Chile, compared with previous prevalence data obtained by similar methodology. In addition, predictive factors associated with anti-HAV prevalence are assessed.
MATERIALS AND METHODS
Study sample and design. The survey was performed to obtain a representative sample of children and young adults in metropolitan Santiago. Sample size estimates were based on the census projections for population size in 1997 and seroprevalence data from 1990 (Vial, unpublished data) based on desired 95% confidence interval half-widths of no more than 10%. Because of the potential interference of placentally acquired antibody in the first year of life, this group was excluded. The sample was stratified by year for the next 4 years of life (ages 2-5) and then by 5-year increments through age 24. Target size for strata was 80 for the second and third years of life and 100 for each subsequent group.
The number of participants to be enrolled per age stratum in each urban residential district (comuna) of metropolitan Santiago was determined on the basis of census estimates of the proportion of the population in each district. Similarly, within the selected districts, for each neighborhood unit (unidad vecinal), the desired number of participants was calculated based on the proportional contribution of the unit to the total population of the district. Nonresidential units were excluded. The study nurses visited the neighborhood units starting with the block located at the northeast point and progressed through the block in a clockwise direction. No more than one individual per household or building was sampled. The youngest available member of each chosen household was recruited until the quotas were met for the youngest age categories, advancing to fill the older categories consecutively. Because poor response was anticipated in the areas of higher socioeconomic status (SES), a different approach was used. For this population, recruitment was performed in ambulatory clinics serving those areas, recruiting individuals who were to undergo venipuncture for other reasons, who were not chronically ill, and who were not being seen for complaints consistent with hepatitis.
After explanation of the study, signed informed consent was obtained from participants (or, in the case of minors, their parents), a questionnaire exploring sociodemographic data and previous exposures and illnesses was administered, and a 5-mL blood sample was obtained.
This study was reviewed and approved by the Institutional Review Board of the University of Maryland, Baltimore, and by the Ministry of Health in Chile.
Laboratory procedures. Serum samples were analyzed for total anti-HAV using a commercial enzyme-linked immuno-sorbent assay kit (Abbott Laboratories, Abbott Park, IL), according to manufacturer's instructions, at the Centro de Investigaciones Mé dicas, Universidad Cató lica de Chile.
Data analysis. Serostatus was determined by dividing the OD of the test sample by the OD of the cutoff value (index value); values of 1.0 or higher were considered positive for anti-HAV and those at 1.0 or lower were considered negative. Seroprevalence was determined according to the age groups of interest as defined previously, with calculation of the 95% confidence intervals (95% CI). An individual was defined as having "higher" socioeconomic status (SES) if he or she lived in a comuna in which less than 8.5% of the population lived in poverty (the highest quartile for this measure among the study sample), as characterized by the biannual sampling of the Ministerio de Planificació n. Comparison of proportions was performed with the chi-square test. Adjustment for age, a consistently strong confounder in studies of seroprevalence, was performed initially using stratification by age group. Age standardization was performed using the age distribution of the general population of Santiago according to census data. Logistic regression was used to adjust for various predictors of anti-HAV status. For the multivariate analysis, SES was categorized as tertiles of levels of poverty within each comuna. In all analyses, differences were regarded as significant at P Յ .05. Analysis was performed with the SAS System for Windows, version 6.12 (SAS Institute, Cary, NC).
RESULTS
The description of the study sample, distribution of the socioeconomic variables, and proportion of anti-HAV within the groups appears in Table 1 . The proportion of individuals in the highest quartile for SES based on the percent of poverty in their respective comunas is similar to the population percentage. A minority of anti-HAV positive individuals reported a history of hepatitis or jaundice.
Both Table 1 and Figure 1 demonstrate the increasing trend of seroprevalence of anti-HAV across the five major age categories ( 2 for trend P-value < 0.0001). Tables 2 and 3 show the unadjusted and age-adjusted associations between anti-HAV serostatus with sociodemographic characteristics and personal history of exposures. Area of residence and both maternal and paternal years of education remained significantly associated with anti-HAV seroprevalence when the analysis was adjusted for age. Table  3 demonstrates decreased risk of anti-HAV with higher SES, use of potable water, use of municipal sewage system, a toilet in the house or outhouse, and a refrigerator in the house after adjusting for age. Past diagnosis of hepatitis or jaundice and exposure to an outbreak of hepatitis increased the risk of anti-HAV positivity after adjusting for age.
The results of logistic regression, adjusting for variables suggested to be significant in the prior analysis or implicated in previous publications, appear in Table 4 . As a result of substantial colinearity between maternal and paternal education, only maternal education was included in the model. It should be noted that the number of individuals responding "no" to questions about municipal sewage connection, use of potable water, having a toilet in the house or outhouse, and owning a refrigerator were low (13, 43, 18, and 57, respectively). Among those of lower SES (proportion of poverty in the respective comunas 8.5% or greater, which excludes the highest quartile for this measure), the age-standardized prevalence of anti-HAV using the census numbers for the four age groups was 40.6% (Table 5 ). The comparison with the agestandardized prevalence from two previous studies that used similar methodology indicates a consistent decrease in seroprevalence across these studies. For our sample, the anti-HAV prevalence standardized by area or SES (proportion of poverty less than 8.5% or 8.5% or greater) were similar: 33.1% and 32.7%, respectively.
DISCUSSION
It appears that HAV infection is decreasing among young children in Santiago, Chile. Such a trend has been suggested in previous publications from Santiago and elsewhere in Chile, 7, 8, 10 similar to trends described in other countries, [11] [12] [13] [14] [15] and is presumably due to improved sanitary conditions. These results support those of a 1996 survey 10 demonstrating a substantial decrease in age-specific prevalence compared with data from 1990 (Vial, unpublished data; see Table 5 ). Moreover, there is evidence that the age-standardized prevalence of anti-HAV among those younger than 20 years and of lower SES has declined during the 1990s, from 53.7% in 1990 (Vial, unpublished data) to 44.8% in 1996. 10 In this study, the agestandardized prevalence of anti-HAV in those of low SES was 40.6%. The advantage in comparing these studies is that all three studies used similar methodology. Not surprisingly, a number of sociodemographic variables were associated with anti-HAV after controlling for age. Residence in areas of lower SES and fewer maternal or paternal years of education were significantly associated with a higher anti-HAV prevalence. HAV infection has been found to be significantly associated with poor hygiene and crowded living situations 2, [16] [17] [18] as well as with more general measures of SES. 10, 19 In the age-stratified analyses, use of potable water, use of a municipal sewage system, use of a toilet/ outhouse, and use of a refrigerator were all significantly associated with anti-HAV serostatus. Although more than 95% of the individuals in the sample reported both usage of potable water and a working sewage system, there is evidence that those lacking such facilities are at increased risk for HAV infection, consistent with findings in Thailand and Brazil. 11, 20 The association between SES and anti-HAV status in this context has been documented elsewhere in the world as well as in Chile. 10, 18, [20] [21] [22] [23] Although ingestion of shellfish or raw shellfish has been found to be associated with HAV, 2,24,25 our data do not support this association after adjusting for age. However, the results of the adjusted analysis, although not significant, are consistent with such an association.
Our data indicate an increasing proportion of HAV susceptible individuals at a time when the virus is clearly still prevalent in these communities. This may in part be due to measures implemented in response to the appearance of cholera in Peru in 1991. 8 The public health significance of the shift of infection to the older age groups is great. Clinically apparent hepatitis A, with greater morbidity and mortality, is more likely with increasing age. [26] [27] [28] Thus, although an increase in the number of clinically apparent cases may be considered a marker of a country's improving conditions, a considerable potential public health burden is generated as the distribution of HAV infection shifts to older ages. 29 In this context, consideration must be given to the feasibility of the introduction of vaccination programs. 3 The availability of HAV vaccines makes it possible for "transitioning" countries to consider preventive measures to decrease morbidity; however, a specific strategy that takes into account vaccine cost and actual availability is needed to implement vaccination in specific regions. 
